Earnings Releases·Nov 4, 2026, 5:03 PM ET

Viemed Healthcare — Third Quarter 2026 Earnings Summary

Net revenue reached a record $80.7 million, up 12.2% year-over-year and 3.3% sequentially, while net income surged 32.0% year-over-year to $4.6 million ($0.11 per share) and Adjusted EBITDA rose 5.8% year-over-year to $17.1 million.
Full-year 2026 net revenue guidance was raised to $316 million–$320 million (previously $314 million–$320 million), and Adjusted EBITDA guidance was narrowed to $64 million–$66 million (previously $64 million–$68 million).
Capital allocation included $1.0 million in share repurchases (115,000 shares) and $2.1 million in term debt repayments, supported by $4.0 million in quarterly free cash flow and $9.7 million in ending cash.
Patient volumes grew across key segments, with PAP therapy patients up 37.5% year-over-year and ventilator rental revenue increasing 7.4% year-over-year to $37.5 million.
Management anticipates sequential revenue and Adjusted EBITDA improvements in Q4 2026, driven by reduced capital intensity as less capital-intensive offerings comprise a larger revenue share.